The Discounted Cash Flow (DCF) valuation of Rigel Pharmaceuticals Inc (RIGL) is 32.74 USD. With the latest stock price at 18.93 USD, the upside of Rigel Pharmaceuticals Inc based on DCF is 72.9%.
Based on the latest price of 18.93 USD and our DCF valuation, Rigel Pharmaceuticals Inc (RIGL) is a buy. buying RIGL stocks now will result in a potential gain of 72.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 10.1% | 8.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 21.21 - 74.59 | 32.74 |
| Upside | 12.0% - 294.0% | 72.9% |